Green Cross

005250 · KO · Healthcare / Biotechnology

9,580.00KRW-140.00 (-1.44%)

Price History

Full chart

Market Stats

Previous Close9,720.00

Open9,750.00

Day Range9,530.00 – 9,940.00

52-Week Range8,630.00 – 18,010.00

Volume77.72K

Market Cap440.39B

P/E (TTM)0.00

Forward P/E74.07

Dividend Yield3.15%

Beta0.57

50-Day Avg9,838.20

200-Day Avg12,862.20

About

GC Corp. operates as a biotechnology company. The company provides prescription drugs and over-the-counter drugs; aseptic fill and finish services for drug manufacturing; and pharmaceutical logistics services. It also researches and develops plasma derivatives for von Willebrand disease and primary immunodeficiency; vaccines for mRNA flu, anthrax, tetanus, diphtheria, pertussis, tuberculosis, and varicella; recombinant treatments for acquired thrombotic thrombocytopenic purpura, fabry, hemophilia, hunterase, colon cancer, and hunter syndrome; and small molecules for gangliosidosis andalagille's syndrome. The company has partnerships and collaborations with biotech companies and academia for development of new drugs and technologies, and clinical trials. Additionally, the company provides personalized nutrition injections. The company was formerly known as Green Cross Holdings Corporation and changed its name to GC Corp. in April 2026. The company was founded in 1967 and is headquartered in Yongin-Si, South Korea.

Company Details

SectorHealthcare
IndustryBiotechnology
CEOMr. Yong-Jun Huh
Employees144
Headquarters107, Ihyeon-ro 30beon-gil, Yongin-Si, South Korea, Korea
Websitehttps://www.gccorp.com

Leadership

Mr. Yong-Jun HuhCEO & Director · b. 1974

Financials

Income Statement

Currency: KRW	2000-12-31	2001-12-31	2002-12-31	2003-12-31	2004-12-31	2005-12-31	2006-12-31	2007-12-31	2008-12-31	2009-12-31	2010-12-31	2011-12-31	2012-12-31	2013-12-31	2014-12-31	2015-12-31	2016-12-31	2017-12-31	2018-12-31	2019-12-31	2020-12-31	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31

Currency: KRW	2000-12-31	2001-12-31	2002-12-31	2003-12-31	2004-12-31	2005-12-31	2006-12-31	2007-12-31	2008-12-31	2009-12-31	2010-12-31	2011-12-31	2012-12-31	2013-12-31	2014-12-31	2015-12-31	2016-12-31	2017-12-31	2018-12-31	2019-12-31	2020-12-31	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Total Revenue	272.58B	275.83B	327.90B	556.92B	758.58B	837.01B	928.42B	1.13T	1.23T	1.52T	1.79T	817.95B	856.58B	938.30B	1.04T	1.13T	1.35T	1.46T	1.55T	1.52T	1.72T	1.84T	2.08T	2.06T	2.20T	2.45T
Growth (%)	-	+1.19%	+18.88%	+69.84%	+36.21%	+10.34%	+10.92%	+22.03%	+8.85%	+23.58%	+17.53%	-54.33%	+4.72%	+9.54%	+11.35%	+8.43%	+19.51%	+8.20%	+5.67%	-1.70%	+12.99%	+7.05%	+12.99%	-1.04%	+7.14%	+11.19%
Cost of Revenue	210.89B	-	206.82B	441.46B	614.06B	675.17B	733.19B	921.19B	1.02T	1.23T	1.45T	519.69B	569.39B	623.33B	686.48B	764.57B	961.70B	1.05T	1.14T	1.10T	1.19T	1.21T	1.38T	1.45T	1.58T	1.77T
Gross Profit	-	-	-	-	-	-	-	-	-	-	-	-	-	297.78B	335.98B	368.30B	392.19B	411.67B	405.81B	426.70B	530.29B	628.54B	698.34B	603.58B	620.36B	682.74B
Gross Margin	-	-	-	-	-	-	-	-	-	-	-	-	-	31.74%	32.16%	32.51%	28.97%	28.10%	26.22%	28.04%	30.84%	34.15%	33.58%	29.33%	28.14%	27.85%
Operating Expense	-	-	-	-	-	-	-	-	-	-	-	-	-	202.87B	220.79B	257.94B	293.51B	300.32B	357.13B	399.37B	459.53B	542.21B	627.18B	620.00B	631.07B	646.28B
Operating Income	-	27.41B	19.55B	25.70B	30.35B	20.50B	48.78B	69.48B	62.97B	131.49B	154.80B	105.78B	88.98B	94.90B	115.19B	110.37B	98.68B	111.36B	48.68B	27.34B	70.76B	86.33B	71.16B	-16.42B	-10.72B	36.46B
Operating Margin	-	9.94%	5.96%	4.61%	4.00%	2.45%	5.25%	6.13%	5.11%	8.63%	8.64%	12.93%	10.39%	10.11%	11.03%	9.74%	7.29%	7.60%	3.14%	1.80%	4.12%	4.69%	3.42%	-0.80%	-0.49%	1.49%
EBITDA	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	151.21B	108.02B	61.58B	185.09B	269.98B	144.76B	66.84B	212.83B	125.72B
EBITDA Margin	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	10.32%	6.98%	4.05%	10.77%	14.67%	6.96%	3.25%	9.65%	5.13%
Net Income	53.12B	6.02B	9.82B	3.63B	923.22M	5.14B	6.11B	24.38B	21.17B	37.36B	67.25B	27.45B	61.23B	43.24B	56.59B	65.42B	47.18B	43.36B	18.47B	2.96B	170.96B	55.27B	32.82B	-54.14B	24.03B	-69.51B
Net Income Margin	19.49%	2.18%	2.99%	0.65%	0.12%	0.61%	0.66%	2.15%	1.72%	2.45%	3.76%	3.36%	7.15%	4.61%	5.42%	5.77%	3.48%	2.96%	1.19%	0.19%	9.94%	3.00%	1.58%	-2.63%	1.09%	-2.84%
R&D	-	-	-	-	-	-	-	-	-	-	55.55B	58.67B	69.21B	75.61B	84.61B	95.51B	109.21B	103.75B	122.41B	126.35B	143.31B	147.28B	193.94B	179.47B	174.64B	157.26B
R&D as % of Total Revenue	-	-	-	-	-	-	-	-	-	-	3.10%	7.17%	8.08%	8.06%	8.10%	8.43%	8.07%	7.08%	7.91%	8.30%	8.34%	8.00%	9.33%	8.72%	7.92%	6.41%
Interest Expense	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	17.55B	18.40B	24.34B	27.52B	36.48B	53.10B	66.57B	72.00B
Interest Expense % of Total Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	1.13%	1.21%	1.42%	1.50%	1.75%	2.58%	3.02%	2.94%

Balance Sheet

Currency: KRW	2000-12-31	2001-12-31	2002-12-31	2003-12-31	2004-12-31	2005-12-31	2006-12-31	2007-12-31	2008-12-31	2009-12-31	2010-12-31	2011-12-31	2012-12-31	2013-12-31	2014-12-31	2015-12-31	2016-12-31	2017-12-31	2018-12-31	2019-12-31	2020-12-31	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31

Currency: KRW	2000-12-31	2001-12-31	2002-12-31	2003-12-31	2004-12-31	2005-12-31	2006-12-31	2007-12-31	2008-12-31	2009-12-31	2010-12-31	2011-12-31	2012-12-31	2013-12-31	2014-12-31	2015-12-31	2016-12-31	2017-12-31	2018-12-31	2019-12-31	2020-12-31	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Total Assets	432.99B	491.42B	406.36B	1.60T	1.62T	1.77T	2.01T	2.43T	2.78T	3.35T	4.11T	4.60T	1.45T	1.62T	1.79T	2.06T	2.25T	2.56T	2.63T	2.77T	3.24T	3.50T	3.59T	3.74T	3.67T	4.07T
Total Liabilities	150.84B	217.49B	187.51B	1.39T	1.41T	1.53T	1.79T	2.08T	2.43T	2.82T	3.27T	3.71T	473.51B	524.46B	609.81B	751.28B	872.27B	1.12T	1.18T	1.27T	1.57T	1.59T	1.63T	1.86T	1.82T	2.31T
Total Equity	272.02B	231.26B	180.13B	169.88B	167.66B	175.46B	152.50B	214.66B	216.24B	309.11B	557.52B	559.26B	621.80B	673.15B	704.68B	730.92B	771.62B	812.81B	804.35B	812.84B	919.30B	1.03T	1.04T	980.25B	994.09B	900.93B
Cash	6.57B	61.71B	33.20B	99.34B	87.95B	70.41B	60.89B	123.92B	107.91B	144.97B	290.42B	43.20B	31.78B	39.19B	47.62B	163.23B	113.58B	268.84B	250.79B	176.46B	447.57B	335.57B	208.64B	174.54B	77.30B	79.66B
Net Debt	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	422.79B	541.67B	637.25B	483.06B	564.85B	717.19B	894.44B	1.01T	1.29T

Cash Flow

Currency: KRW	2000-12-31	2001-12-31	2002-12-31	2003-12-31	2004-12-31	2005-12-31	2006-12-31	2007-12-31	2008-12-31	2009-12-31	2010-12-31	2011-12-31	2012-12-31	2013-12-31	2014-12-31	2015-12-31	2016-12-31	2017-12-31	2018-12-31	2019-12-31	2020-12-31	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31

Currency: KRW	2000-12-31	2001-12-31	2002-12-31	2003-12-31	2004-12-31	2005-12-31	2006-12-31	2007-12-31	2008-12-31	2009-12-31	2010-12-31	2011-12-31	2012-12-31	2013-12-31	2014-12-31	2015-12-31	2016-12-31	2017-12-31	2018-12-31	2019-12-31	2020-12-31	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Operating Cash Flow	53.91B	31.86B	-	182.96B	-	62.29B	104.03B	262.77B	167.47B	482.60B	355.62B	116.18B	36.80B	17.57B	54.54B	7.04B	-805.47M	144.48B	37.64B	7.65B	35.77B	103.77B	97.16B	-39.65B	-89.95B	24.30B
Investing Cash Flow	-	-	27.64B	-	77.68B	-	-	-	-	-	-	-	-	-93.00B	-102.86B	-20.06B	-199.55B	-157.28B	-171.70B	-191.06B	-98.80B	-110.21B	-	-	-	-
Financing Cash Flow	-	-	-	67.89B	14.94B	958.81M	-	43.13B	59.02B	-	187.54B	-	-	85.88B	55.34B	126.32B	143.77B	183.55B	114.63B	105.44B	387.52B	-116.46B	-	-	-	-
Capital Expenditure	19.00B	16.09B	12.61B	14.48B	26.94B	22.94B	38.29B	72.93B	60.28B	71.65B	37.48B	48.70B	75.48B	99.58B	78.26B	151.83B	179.47B	196.26B	118.00B	138.93B	108.48B	116.60B	127.18B	132.62B	57.72B	150.06B
Free Cash Flow	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-66.61B	-110.36B	-157.35B	-97.57B	-38.07B	-30.02B	-172.27B	-147.67B	-125.76B
Dividends Paid	3.44B	7.32B	6.02B	7.70B	4.70B	6.15B	7.50B	7.85B	16.43B	10.95B	9.10B	21.65B	18.81B	26.19B	18.83B	21.36B	23.87B	22.06B	22.11B	18.28B	21.46B	32.24B	31.50B	29.93B	25.43B	33.21B
FCF to OCF	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-46.10%	-293.18%	-2056.82%	-272.75%	-36.68%	-30.90%	434.42%	164.17%	-517.54%
Dividend Paid to FCF	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-33.13%	-20.04%	-11.62%	-21.99%	-84.69%	-104.92%	-17.38%	-17.22%	-26.40%

Earnings

Report Date	Mar 31, 2011	Jun 30, 2011	Sep 30, 2011	Mar 31, 2012	Jun 30, 2012	Sep 30, 2012	Dec 31, 2012	Mar 31, 2013	Jun 30, 2013	Sep 30, 2013	Dec 31, 2013	Mar 31, 2014	Jun 30, 2014	Sep 30, 2014	Dec 31, 2014	Mar 31, 2015	Jun 30, 2015	Sep 30, 2015	Dec 31, 2015	Mar 31, 2016	Aug 16, 2016	Nov 14, 2016	Feb 2, 2017	May 15, 2017	Jun 30, 2017	Nov 14, 2017	Mar 13, 2018	Mar 31, 2018	Jun 30, 2018	Sep 30, 2018	Dec 31, 2018	Mar 31, 2019	Jun 30, 2019	Sep 30, 2019	Dec 31, 2019	May 15, 2020	Aug 14, 2020	Nov 16, 2020	Feb 9, 2021	May 17, 2021	Aug 17, 2021	Nov 15, 2021	Feb 14, 2022	May 16, 2022	Aug 16, 2022	Nov 14, 2022	Feb 14, 2023	May 15, 2023	Aug 14, 2023	Nov 14, 2023	Mar 28, 2024	May 16, 2024	Aug 14, 2024	Nov 12, 2024	Feb 6, 2025	May 15, 2025	Aug 12, 2025	Nov 12, 2025	Dec 31, 2025	May 13, 2026	Jun 30, 2026
EPS Estimate	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
EPS Actual	414.68	240.45	412.98	1979.49	166.82	363.06	-971.60	335.89	205.01	393.30	33.47	319.51	213.74	623.82	87.54	216.59	477.13	680.47	65.06	50.75	253.10	187.59	547.65	120.09	368.23	344.56	122.24	476.73	-100.01	90.24	-60.22	59.98	-212.29	129.77	87.67	-54.04	604.92	515.45	2699.18	291.71	30.89	444.08	450.68	-42.85	-138.92	46.13	858.59	-564.72	-232.05	-185.62	-209.99	-897.91	-366.81	-23.63	1817.52	64.60	747.37	201.86	-2542.69	-381.23	34.04
Surprise	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Timing	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	Pre-market	Pre-market	After-hours	Pre-market	-	Pre-market	Pre-market	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	Pre-market	Pre-market	Pre-market	After-hours	After-hours	After-hours	After-hours	After-hours	Pre-market	After-hours	After-hours	After-hours	Pre-market	Pre-market	Pre-market	Pre-market	-	Pre-market	-

Key Statistics & Ratios

Market Cap440.39B

Enterprise Value2.01T

Trailing P/E0.00

Forward P/E74.07

PEG Ratio0.00

Price / Sales0.18

Price / Book0.49

Revenue (TTM)2.49T

Gross Profit (TTM)679.07B

EBITDA136.98B

Profit Margin-4.91%

Operating Margin1.11%

Return on Equity-8.38%

Return on Assets0.44%

Shares Outstanding44.97M

Shares Float24.95M

Beta0.57

Dividend Yield3.15%

Dividend Rate300.00

Payout Ratio0.00%

Dividends

20261×

300.00Mar 30, 2026

20241×

500.00Dec 27, 2024

20231×

300.00Dec 27, 2023

20221×

300.00Dec 28, 2022

20211×

400.00Dec 29, 2021

20201×

500.00Dec 29, 2020

20191×

325.00Dec 27, 2019

20181×

250.00Dec 27, 2018

20171×

300.00Dec 27, 2017

20161×

300.00Dec 28, 2016

20151×

300.00Dec 29, 2015

20141×

300.00Dec 29, 2014

20131×

250.00Dec 27, 2013

20121×

450.00Dec 27, 2012

20111×

250.00Dec 28, 2011

20101×

295.45Dec 29, 2010

20091×

227.27Dec 29, 2009

20081×

181.82Dec 29, 2008

20071×

181.82Dec 27, 2007

20061×

136.36Dec 27, 2006

20051×

136.36Dec 28, 2005

20041×

136.36Dec 29, 2004

20031×

113.64Dec 29, 2003

20021×

136.36Dec 27, 2002

Stock Splits

Apr 18, 201110:1
Jan 31, 20111.1:1